These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2866790

  • 1. Clinical evaluation of betaxolol (Kerlone) as a once-daily treatment for hypertension in 4685 patients.
    Djian J.
    Br J Clin Pract; 1985 May; 39(5):188-91. PubMed ID: 2866790
    [No Abstract] [Full Text] [Related]

  • 2. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA.
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract] [Full Text] [Related]

  • 3. [Antihypertensive effect of betaxolol at increasing doses].
    Pathe M, Steimer C, Schwartz J.
    Therapie; 1982 Jul; 37(1):75-82. PubMed ID: 6124052
    [No Abstract] [Full Text] [Related]

  • 4. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL.
    Ugeskr Laeger; 1975 Sep 22; 137(39):2274-6. PubMed ID: 241148
    [No Abstract] [Full Text] [Related]

  • 5. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A, Hany S, Bättig B, Jenni R, Troesch M, Willimann P, Graf A, Leutenegger F, Angehrn V, Beck G.
    Schweiz Rundsch Med Prax; 1988 Oct 11; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract] [Full Text] [Related]

  • 6. [Changes in hemodynamics and renal function during the oral administration of betaxolol].
    Pathe M, Schwartz J.
    Therapie; 1985 Oct 11; 40(4):209-12. PubMed ID: 2862715
    [No Abstract] [Full Text] [Related]

  • 7. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A.
    Ther Hung; 1986 Oct 11; 34(3):171-4. PubMed ID: 2894722
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P.
    Arzneimittelforschung; 1987 Dec 11; 37(12):1370-2. PubMed ID: 2896506
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of a beta-blocking agent in a single daily dose].
    Di Veroli C, Compagno S.
    Clin Ter; 1982 Jun 30; 101(6):623-8. PubMed ID: 6127182
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of arotinolol hydrochloride on hemodynamics, catecholamine levels and metabolism in patients with essential hypertension].
    Morimoto Y, Kasai A, Nagano K, Umino M, Kakuta Y, Iwata J, Konishi T, Hamada M, Nakano T.
    Kokyu To Junkan; 1988 Mar 30; 36(3):311-5. PubMed ID: 2453908
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspects.
    Chrysant SG, Chrysant C, Bal IS, Trus J, Hitchcock A.
    Chest; 1989 Sep 30; 96(3):499-504. PubMed ID: 2569959
    [Abstract] [Full Text] [Related]

  • 12. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L, Henningsen NC, Karlberg B, Aberg H, Jameson S, Malmcrona R, Hersvall C.
    Int J Clin Pharmacol; 1974 Oct 30; 10(3):206-11. PubMed ID: 4154313
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D, Savonelli C, Maggi GC.
    Minerva Cardioangiol; 1983 Nov 30; 31(11):671-6. PubMed ID: 6142433
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].
    Herpin D, Boutaud P, Ciber MA, Amiel A, Demange J.
    Ann Cardiol Angeiol (Paris); 1987 Nov 30; 36(9):487-93. PubMed ID: 2892458
    [Abstract] [Full Text] [Related]

  • 15. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A, Pyöräiä K.
    Duodecim; 1976 Nov 30; 92(11):597-603. PubMed ID: 7445
    [No Abstract] [Full Text] [Related]

  • 16. [Use of Cordanum in labile hypertension].
    Gerasimiuk PP, Zaporozhets TF, Slobodianik GP.
    Vrach Delo; 1982 Nov 30; (11):29-30. PubMed ID: 6130655
    [No Abstract] [Full Text] [Related]

  • 17. [Long-term beta adrenergic antagonists in spastic bronchopathies].
    Blaive B, Nahon F, Lemoigne F, Lewest G.
    Allerg Immunol (Paris); 1988 Apr 30; 20(4):161-2, 164-5. PubMed ID: 2900013
    [Abstract] [Full Text] [Related]

  • 18. The blood pressure responses of thiazide-resistant hypertensives to a once-a-day bevantolol regimen.
    Snedden W, Fernandez PG, Nath C.
    Can J Cardiol; 1987 Oct 30; 3(7):322-5. PubMed ID: 2892582
    [Abstract] [Full Text] [Related]

  • 19. [Long-term administration of trimepranol in young men with labile borderline hypertension and its influence on plasma renin activity (author's transl)].
    Slabý A, Dosková M, Jirák R, Pavlát J, Urbánek J, Reisenauer R.
    Sb Lek; 1975 Apr 30; 77(4):107-11. PubMed ID: 238278
    [No Abstract] [Full Text] [Related]

  • 20. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K, Zhang B, Okamoto T, Takeda Y, Liu K, Jimi S, Arakawa K.
    J Hum Hypertens; 1996 Apr 30; 10(4):263-8. PubMed ID: 8736459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.